ESC 365 - Inflammation management in ASCVD and AMI: what the clinical guidelines say

Open Access

Inflammation management in ASCVD and AMI: what the clinical guidelines say

Session: Unravelling cardiovascular inflammation in atherosclerotic cardiovascular disease (ASCVD): from evidence to guidance

Topic: Inflammation

Speaker: Professor F. Andreotti (Rome, IT)

Sponsored by Novo Nordisk

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Felicita Andreotti

IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)

31 presentations

9 followers

4 more presentations in this session

Why are we here?

Speaker: Professor R. Mehran (New York, US)

Inflammatory biomarkers: why measure hsCRP as well as LDL?

Speaker: Doctor P. Ridker (Boston, US)

Targeting inflammation in acute myocardial infarction: what, when, who?

Speaker: Doctor C. Matter (Zurich, CH)

Summary, Q&A and close

Access the full session

Unravelling cardiovascular inflammation in atherosclerotic cardiovascular disease (ASCVD): from evidence to guidance

Speakers: Professor F. Andreotti, Professor R. Mehran, Doctor P. Ridker, Doctor C. Matter

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources